Development of laboratory and animal model systems for HIV-1 encephalitis and its associated dementia

被引:48
作者
Persidsky, Y
Gendelman, HE
机构
[1] UNIV NEBRASKA, MED CTR, DEPT MED, OMAHA, NE 68198 USA
[2] UNIV NEBRASKA, MED CTR, EPPLEY INST RES CANC & ALLIED DIS, OMAHA, NE 68198 USA
关键词
macrophage; blood-brain barrier;
D O I
10.1002/jlb.62.1.100
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The neuropathogenesis of HIV-1 encephalitis and its associated dementia revolves around sustained viral replication in cells of mononuclear phagocyte origin (brain macrophages, multinucleated giant sells, and microglia), Macrophage secretory factors play important roles in facilitating monocyte trafficking into the brain, in regulating productive viral replication, and in producing neurotoxic responses, To study these events, we constructed an artificial blood-brain barrier (BBB) to assay monocyte transendothelial migration and developed an animal model system for HIV-1 encephalitis to ascertain the role that virus-infected mononuclear phagocytes play in disease pathogenesis, The BBB model was composed of brain microvascular endothelial cells and astrocytes placed on opposite sides of a porous membrane, Monocyte activation, not HIV-1 infection per se, was the central event affecting monocyte BBB migration, Many of the pathological features of HIV-1 encephalitis were reproduced in SCID mice stereotactically inoculated with virus-infected monocytes, These included widespread astrogliosis, apoptosis of neurons, dendritic damage, and macrophage/microglial activation. Such laboratory and animal model systems are being used to ascertain the pathogenic potential of virus-infected macrophages in brain and ways to curb such injurious effects.
引用
收藏
页码:100 / 106
页数:7
相关论文
共 62 条
[1]  
ADAMSON CD, 1996, SCIENCE, V274, P1917
[2]  
BASARGU O, 1996, AIDS, V10, P573
[3]  
BERGER JR, 1995, TECHNICAL ADVANCES IN AIDS RESEARCH IN THE HUMAN NERVOUS SYSTEM, P3
[4]   AIDS DEMENTIA COMPLEX AND HIV-1 BRAIN INFECTION - CLINICAL-VIROLOGICAL CORRELATIONS [J].
BREW, BJ ;
ROSENBLUM, M ;
CRONIN, K ;
PRICE, RW .
ANNALS OF NEUROLOGY, 1995, 38 (04) :563-570
[6]   REGULATION OF NITRIC-OXIDE SYNTHASE ACTIVITY IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-INFECTED MONOCYTES - IMPLICATIONS FOR HIV-ASSOCIATED NEUROLOGICAL DISEASE [J].
BUKRINSKY, MI ;
NOTTET, HSLM ;
SCHMIDTMAYEROVA, H ;
DUBROVSKY, L ;
FLANAGAN, CR ;
MULLINS, ME ;
LIPTON, SA ;
GENDELMAN, HE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) :735-745
[7]   MICROGLIA AND CYTOKINES IN NEUROLOGICAL DISEASE, WITH SPECIAL REFERENCE TO AIDS AND ALZHEIMERS-DISEASE [J].
DICKSON, DW ;
LEE, SC ;
MATTIACE, LA ;
YEN, SHC ;
BROSNAN, C .
GLIA, 1993, 7 (01) :75-83
[8]   HIV type 1 V3 sequences and the development of dementia during AIDS [J].
DiStefano, M ;
Wilt, S ;
Gray, F ;
DuboisDalcq, M ;
Chiodi, F .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (06) :471-476
[9]   HIV INTERACTIONS WITH CELLS OF THE NERVOUS-SYSTEM [J].
DUBOISDALCQ, M ;
ALTMEYER, R ;
CHIRON, M ;
WILT, S .
CURRENT OPINION IN NEUROBIOLOGY, 1995, 5 (05) :647-655
[10]   HIV-1 V3 DOMAIN VARIATION IN BRAIN AND SPLEEN OF CHILDREN WITH AIDS - TISSUE-SPECIFIC EVOLUTION WITHIN HOST-DETERMINED QUASISPECIES [J].
EPSTEIN, LG ;
KUIKEN, C ;
BLUMBERG, BM ;
HARTMAN, S ;
SHARER, LR ;
CLEMENT, M ;
GOUDSMIT, J .
VIROLOGY, 1991, 180 (02) :583-590